Specifically, potassium channel activation-dependent Cav-1 dephosphorylation was observed in highly metastatic breast cancer cells, suggesting that targeting this pathway could be a novel therapeutic approach to inhibit cancer cell migration and enhance contact inhibition [165]. Here, CAV1 is linked to breast carcinoma.